Combined Antiviral Therapy Reduces Hiv-1 Plasma Load and Improves CD4 Counts But Does Not Intere with Ongoing Lymphocyte Apoptosis

References

• Mellors J. W., Rinaldo C. R., Jr, Gupta P., White R. M., Todd J. A., Kingsley L A. Prognosis In HIV-1 Infection Predicted By The Quantity Of Virus In Plasma. Science 1996; 272: 1167
   PubMed Web of Science ®Google Scholar
• Mellors J. W., Kingsley L. A., Rinaldo C. R., Jr, et al. Quantitation Of HIV-1 RNA In Plasma Predicts Outcome After Seroconversion. Ann. Intern. Med. 1995; 122: 573
   PubMed Web of Science ®Google Scholar
• Jurriaans S., Van Gemen B., Weverling G. J., et al. The Natural History Of HIV-1 Infection: Virus Load And Virus Phenotype Independent Determinants Of Clinical Course?. Virology 1994; 204: 223
   PubMed Web of Science ®Google Scholar
• Henrard D. R., Philips J. F., Muenz L. R., et al. Natural History Of HIV-1 Cell-free Viremia. JAMA 1995; 274: 554
   PubMed Web of Science ®Google Scholar
• Fauci A. S., Pantaleo G., Stanley S., Weissman D. Immunopathogenic Mechanisms Of HIV Infection. Ann. Intern. Med. 1996; 124: 654
   PubMed Web of Science ®Google Scholar
• Pantaleo G., Graziosi C., Demarest J. F., et al. HIV Infection Is Active And Progressive In Lymphoid Tissue During The Clinically Latent Stage Of Disease. Nature 1993; 362: 355
   PubMed Web of Science ®Google Scholar
• Faust R. A., Henry K., Dailey P., et al. Outpatient Biopsies Of The Palatin Tonsil: Access To Lymphoid For Assessment Of Human Immunodeficiency Virus RNA Titers. Otolaryngol. Head Neck. Surg. 1996; 114: 593
   PubMedGoogle Scholar
• Lafeuillade A., Poggi C., Profizi N., Tamalet C., Costes O. Human Immunodeficiency Virus Type 1 Kinetics In Lymph Nodes Compared With Plasma. J. Infect. Dis. 1996; 174: 404
   PubMedGoogle Scholar
• Cohen O. J., Pantaleo G., Holodniy M., et al. Decreased Human Immunodeficiency Virus Type 1 Plasma Viremia During Antiretroviral Therapy Reflects Down Regulation Of Viral Replication In Lymphoid Tissue. Proc. Natl. Acad. Sci. USA 1995; 92: 6017
   PubMedGoogle Scholar
• Cohen O. J., Pantaleo G., Holodniy M., et al. Antiretroviral Monotherapy In Early Stage Human Immunodeficiency Virus Disease Has No Detectable Effect On Virus Load In Peripheral Blood And Lymph Nodes. J. Infect. Dis. 1996; 173: 849
   PubMedGoogle Scholar
• Erice A., Daileym P., Haasem A., et al. HIV RNA Levels In Lymphoid Tissue, Peripheral Blood Leukocytes (PBMC) And Plasma (PL) Fractions Of HIV-Infected Individuals [abstract 260]. Program and abstracts of the Third Conferences on Retroviruses and Opportunistic Infections. Infectious Diseases Society of America, Washington, D.C. 1996, Aexandria, Virginia
   Google Scholar
• Meylan P. R.A., Burgisser P., Weyrich-Suter C., Spertini F. Viral Load And Immunophenotype Of Cells Obtained From Lymph Nodes By Fine Needle Aspiration As Compared With Peripheral Blood Cells In HIV-Infected Patients. J. Acquired Immune Defic. Syndr. 1996; 13: 39
   Google Scholar
• De Gruttola V., Fleming T., Lyn D. Y., Coombs R. Validating Surrogate Markers. Are We Being Naive. J. Infect. Dis. 1997; 175: 237
   PubMed Web of Science ®Google Scholar
• Fessel W. J. Human Immunodeficiency Virus (HIV) RNA In Plasma As The Preferred Target For Therapy In Patients With HIV Infection: A Critique. Clin. Infect. Dis. 1997; 24: 116
   PubMedGoogle Scholar
• Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid Turnover Of Plasma Virions And CD4 Lymphocytes In HIV-1 Infection. Nature 1995; 373: 123
   PubMed Web of Science ®Google Scholar
• Wei X., Ghosh S. K., Taylor M. E., et al. Viral Dynamic In Human Immunodeficiency Virus Type 1 Infection. Nature 1995; 373: 117
   PubMed Web of Science ®Google Scholar
• Perelson A. S., Neumann A. U., Markowitz M., Leonard J. M., Ho D. D. HIV-1 Dynamic In Vivo Virion Clearance Rate, Infected Cell Life-Span, And Viral Generation Time. Science 1996; 271: 1582
   PubMed Web of Science ®Google Scholar
• Finkel T. H., Tudor-Williams G., Banda N. K, et al. Apoptosis Occurs Predominantly In Bystander Cells And Not In Productively Infected Cells Of HIV- And SIV-Infected Lymph Nodes. Nat. Med. 1995; 2: 129
   Google Scholar
• Bofill M., Gombert W., Borthwick N. J., et al. Presence Of CD3+ CD8+ Bcl-2 Low Lymphocytes Undergoing Apoptosis And Activated Macrophages In Lymph Nodes Of HIV-1 + Patients. Am. J. Pathol. 1995; 146: 1542
   PubMedGoogle Scholar
• Muro-Cacho C. A., Pantaleo G., Fauci A. S. Analysis Of Apoptosis In Lymph Nodes Of HIV-Infected Persons: Intensity Of Apoptosis Correlates With The General State Of Activation Of The Lymphoid Tissue And Not With The Stage Of Disease Or Viral Burden. J. Immunol. 1995; 154: 5555
   PubMedGoogle Scholar
• Meyaard L., Otto S. A., Jonker R. R., Mijnster M. J., Keet R. P., Miedema F. Programmed Death Of T Cells In HIV-1 Infection. Science 1992; 257: 217
   PubMed Web of Science ®Google Scholar
• Groux H., Torpier G., Monte D., Mouton Y., Capron A., Ameisen J. C. Activation-Induced Death By Apoptosis In CD4+ T Cells From Human Immunodeficiency Virus-Infected Asymptomatic Individuals. J. Exp. Med. 1992; 175: 331
   PubMed Web of Science ®Google Scholar
• Gougeon M. L., Montagnier L. Apoptosis In AIDS. Science 1993; 260: 1269
   PubMed Web of Science ®Google Scholar
• Gougeon M. L., Garcia S., Heeney J., Tschopp R., et al. Programmed Cell Death In AIDS-Related HIV And SIV Infections. AIDS Res. Hum. Retroviruses 1993; 9: 553
   PubMedGoogle Scholar
• Lewis D. E., Ng Tang D. S., Adu-Oppong A., Schober W., Rodgers J. R. Anergy And Apoptosis In CD8+ T Cells From HIV-Infected Persons. J. Immunol. 1994; 153: 412
   PubMedGoogle Scholar
• Gougeon M. L., Lecoeur H., Dulioust A., et al. Programmed Cell Death In Peripheral Lymphocytes From HIV-Infected Persons: The Increased Susceptibility To Apoptosis Of CD4 And CD8 T Cells Correlates With Lymphocyte Activation And With Disease Progression. J. Immunol. 1996; 156: 3509
   PubMed Web of Science ®Google Scholar
• Boudet F., Lecoeur H., Gougeon M. L. Apoptosis Associated With Ex Vivo Downregulation Of Bcl-2 And Upregulation Of Fas In Potential Cytotoxic CD8+ T Lymphocytes. J. Immunol. 1996; 156: 2282
   PubMed Web of Science ®Google Scholar
• De Simone C., Cifone M. G., Di Marzio L., et al. Cell-Associated Ceramide In HIV-1-Infected Subjects. AIDS 1996; 10: 675
   PubMedGoogle Scholar
• De Simone C., Famularo G., Cifone M. G., Mitsuya H. HIV-1 Infection And Cellular Metabolism. Immunol. Today 1996; 17: 256
   PubMedGoogle Scholar
• Katsikis P. O., Wundertich E. S., Craig C. A., Herzenberg L. A. Fas Antigen Stimulation Induced Marked Apoptosis Of T Lymphocytes In HIV Virus-Infected Individuals. J. Exp. Med. 1995; 181: 2029
   PubMed Web of Science ®Google Scholar
• Aries S. P., Schaaf B., Muller C., Dennin R. H., Dalhoff K. Fas (CD95) Expression On CD4+ T Cells From HIV-Infected Patients Increases With Disease Progression. J. Mol. Med. 1995; 73: 591
   PubMedGoogle Scholar
• Silvestris F., Cafforio P., Frassanito F. A., et al. Overexpression Of Fas Antigen On T Cells In Advanced HIV-1 Infection: Differential Ligation Constantly Induces Apoptosis. AIDS 1996; 10: 131
   PubMed Web of Science ®Google Scholar
• Sloand E. M., Young N. S., Kumar P., Weichold F. F., Sato T., Maciejewski J. P. Role Of Fas Ligand And Receptor In The Mechanism Of T-Cell Depletion In Acquired Immunodeficiency Syndrome: Effect On CD4+ Lymphocyte Depletion And Human Immunodeficiency Virus Replication. Blood 1997; 89: 1357
   PubMed Web of Science ®Google Scholar
• Debatin K. M., Fahrig-Faissner A., Enenkel-Stoodt S., Kreuz W., Benner A., Krammer P. M. High Expression Of APO-1 (CD95) On T Lymphocytes From Human Immunodeficiency Virus-1-Infected Children. Blood 1994; 83: 3101
   PubMed Web of Science ®Google Scholar
• McCloskey T. W., Oyaizu N., Kaplan M., Pahwa S. Expression Of The Fas Antigen In Patients Infected With Human Immunodeficiency Virus. Cytometry 1995; 22: 111
   PubMedGoogle Scholar
• Oyaizu N., McCloskey T. W., Than S., Hu R., Pahwa S. Mechanisms Of Apoptosis In Peripheral Blood Mononuclear Cells Of HIV-Infected Patients. Adv. Exp. Med. Biol. 1995; 374: 101
   PubMedGoogle Scholar
• Estaquier J., Tanaka M., Suda T., Nagata S., Golstein P., Ameisen J. C. Fas-Mediated Apoptosis Of CD4+ And CD8+ T Cells From Human Immunodeficiency Virus-Infected Persons: Differential In Vitro Preventive Effect Of Cytokines And Protease Antagonists. Blood 1996; 87: 4959
   PubMedGoogle Scholar
• Gougeon M. L., Lecoeur H., Boudet F., et al. Lack Of Chronic Immune Activation In HIV-Infected Chimpanzees Correlates With The Resistance Of T Cells To Fas/Apo-1 (CD95)-Induced Apoptosis And Preservation Of A T Helper 1 Phenotype. J. Immunol. 1997; 158: 2964
   PubMedGoogle Scholar
• Gehri R., Hahn S., Rothen M., Steuerwald M., Nuesch R., Erb P. The Fas Receptor In HIV Infection: Expression On Peripheral Blood Lymphocytes And Role In The Depletion Of T Cells. AIDS 1996; 10: 9
   PubMedGoogle Scholar
• Westendorp M. O., Frank R., Oschsenbauer C., et al. Sensitization Of T Cells To CD95-Mediated Apoptosis By HIV-1 Tat And gp120. Nature 1995; 375: 497
   PubMed Web of Science ®Google Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355
   PubMed Web of Science ®Google Scholar
• Cifone M. G., De Maria R., Roncaioli P., et al. Apoptotic Signaling Through CD95 (Fas/Apo-1) Activates An Acidic Sphingomyelinase. J. Exp. Med. 1994; 177: 1547
   Google Scholar
• Cifone M. G., Roncaioli P., De Maria R., et al. Multiple Pathways Originate At The Fas/Apo-1 (CD95) Receptor: Sequential Involvement Of Phosphatidylcholine-Specific Phospholipase C And Acidic Sphingomyelinase In The Propagation Of The Apoptotic Signal. EMBO J. 1995; 14: 5859
   PubMed Web of Science ®Google Scholar
• Westendorp M. O., Shatrov V. A., Schultze-Osthoff K., et al. HIV-1 Tat Potentiates TNF-Induced NF-kB Activation And Cytotoxicity By Altering The Cellular Redox State. EMBO J. 1995; 14: 546
   PubMed Web of Science ®Google Scholar
• Schreck R., Rieber P., Bauerle P. A. Reactive Oxygen Intermediates As Apparently Widely Used Messengers In The Activation Of The NF-kB Transcription Factor And HIV-1. EMBO J. 1991; 10: 2247
   PubMed Web of Science ®Google Scholar
• Greenspan H. C., Aruoma O. I. Oxidative Stress And Apoptosis In HIV Infection: A Role For Plant-Derived Metabolites With Synergistic Antioxidant Activity. Immunol. Today 1994; 15: 209
   PubMedGoogle Scholar
• Boyum A. Isolation Of Mononuclear Cells And Granulocytes From Human Blood. Scand. J. Clin. Invest. 1968; 97(Suppl 21)77
   Google Scholar
• Nicoletti I., Migliorati G., Pagliacci C., Grignani F., Riccardi C. A Rapid And Simple Method For Measuring Thymocyte Apoptosis By Propidium Iodide Staining And Flow Cytometry. J. Immunol. Methods 1968; 139: 271
   Google Scholar
• Schmid I., Uittenbogaart C. H., Keld B., Giorgi J. V. A Rapid Method For Measuring Apoptosis And Dual-Color Immunofluorescence By Single Laser Flow Cytometry. J. Immunol. Methods 1994; 170: 145
   PubMed Web of Science ®Google Scholar
• Zamzami N., Marchetti P., Castedo M., et al. Reduction In Mitochondrial Potential Constitutes An Early Irreversible Step Of Programmed Lymphocyte Death In Vivo. J. Exp. Med. 1995; 181: 1661
   PubMed Web of Science ®Google Scholar
• Rothe G., Valet G. Flow Cytometric Analysis Of Respiratory Burst Activity In Phagocytes With Hydroethidine And 2′, 7′-Dichlorofluorescin. J. Leukoc. Biol. 1990; 47: 440
   PubMed Web of Science ®Google Scholar
• Wyllie A. N., Morris R. G., Smith A. L., Dunlop D. Chromatin Cleavage In Apoptosis: Association With Condensed Chromatin Morphology And Dependence On Macromolecular Synthesis. J. Pathol. 1991; 142: 67
   Google Scholar
• Dive C., Gregory C. D., Phipps D. J., Evans D. L., Milner A. E., Wyllie A. H. Analysis And Discrimination Of Necrosis And Apoptosis (Programmed Cell Death) By Multiparameter Flow Cytometry. Biochim. Biophys. Acta 1992; 1133: 275
   PubMed Web of Science ®Google Scholar
• Kroemer G., Zamzami N., Susin S. A. Mitochondrial Control Of Apoptosis. Immunol. Today 1997; 18: 44
   PubMedGoogle Scholar
• Sailaja G., Nayak R., Antony A. Azidothymidine Induces Apoptosis In Mouse Myeloma Cell Line sp2/0. Biochem. Pharmacol. 1996; 52: 857
   PubMed Web of Science ®Google Scholar
• Cordiali-Fei P., Solmome M., Viora M., et al. Apoptosis In HIV Infection: Protective Role Of IL-2. Biol. Regul. Homeost. Agents 1994; 8: 60
   PubMedGoogle Scholar
• Zamzami N., Marchetti P., Castedo M., et al. Sequential Reduction Of Mitochondrial Transmembrane Potential And Generation Of Reactive Oxygen Species In early Programmed Cell Death. J. Exp. Med. 1995; 182: 367
   PubMed Web of Science ®Google Scholar
• Petit P. X., LeCoeur H., Zorn E., Dauguet C., Mignotte B., Gougeon M. L. Alterations Of Mitochondrial Structure And Function Are Early Events Of Dexamethasone-Induced Thymocyte Apoptosis. J. Cell. Biol. 1995; 130: 157
   PubMed Web of Science ®Google Scholar
• Heeney J., Jonker J., Koornstra W., et al. The Resistance Of HIV-Infected Chimpanzees To Progression To AIDS Correlates With Absence Of HIV-Related Dysfunction. J. Med. Primatol. 1993; 22: 194
   PubMedGoogle Scholar
• Estaquier J., Idziorek T., de Bels F., et al. Programmed Cell Death And AIDS: Significance Of T Cell Apoptosis In Pathogenic And Nonpathogenic Primate Lentiviral Infections. Proc. Natl. Acad. Sci. USA 1994; 91: 9341
   Google Scholar
• Moretti S., Marcellini S., Boschini A., et al. Apoptosis And Apoptosis-Associated Perturbations Of Peripheral Blood Lymphocytes During HIV Infection: Comparison Between AIDS Patients And Long-Term Nonprogressors, submitted
   Google Scholar
• Cohen D. A., Fitzpatrick E. A., Barve S. S., et al. Activation-Dependent Apoptosis In CD4+ T Cells During Murine AIDS. Cell. Immunol. 1993; 151: 392
   PubMed Web of Science ®Google Scholar
• Willett B. J., Flynnm J. N., Hosie M. J. FIV Infection Of The Domestic Cat: An Animal Model For AIDS. Immunol. Today 1997; 18: 182
   PubMedGoogle Scholar
• Kovacs J. A., Vogel S., Albert J. M., et al. Controlled Trial Of Interleukin-2 Infusions In Patients Infected With Human Immunodeficiency Virus. N. Engl. J. Med. 1996; 335: 1350
   PubMed Web of Science ®Google Scholar
• Davey R. T., Jr, Chaitt D. G., Piscitelli S. C., et al. Subcutaneous Administration Of Interieukin-2 In Human Imunodeficiency Virus Type 1-Infected Persons. J. Infect. Dis. 1997; 175: 781
   PubMed Web of Science ®Google Scholar